CASI Pharmaceuticals, Inc. (OTC:CASIF) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Huang Other companies: Connect Biopharma Holdings Limited (Founding Partner of Panacea Venture · Since at least Mar 18, 2026); Atara Biotherapeutics, Inc. (Human Capital · Since at least May 16, 2025); Orion Biotech Opportunities Corp (Chief Executive Officer, Director · May 12, 2021 – May 17, 2023 · Past); Alaunos Therapeutics, Inc. (Director · Jul 20, 2020 – Jun 6, 2023 · Past); Windtree Therapeutics, Inc. (Director · Dec 21, 2018 – Feb 22, 2023 · Past) | Director · Since at least Mar 18, 2026 |
| Alexander A Zukiwski | Global Chief Medical Officer · Since at least Mar 18, 2026 |
| Alex Wu | Director · Since at least Nov 4, 2026 |
| Chunhua Wang | Chief Operating Officer · Since at least Mar 18, 2026 |
| Frank Su | Director · Since at least Nov 4, 2026 |
| Hai Huang | Global Chief Commercial Ofcr · Since at least Mar 18, 2026 |
| Junping Chen | Chief Medical Officer · Since at least Nov 5, 2026 |
| Kun Qian | Global Controller · Since at least Mar 18, 2026 |
| Thomas Folinsbee | Director · Since at least Mar 18, 2026 |
| Wei Gao | General Counsel · Since at least Nov 5, 2026 |
| Wei-Wu He | Executive Chairman · Since at least Nov 5, 2026 |
| Xuebo Zeng | Director · Since at least Mar 18, 2026 |